AMPH
Price
$23.20
Change
-$0.38 (-1.61%)
Updated
Jul 3 closing price
Capitalization
2.11B
36 days until earnings call
AMRX
Price
$8.42
Change
+$0.05 (+0.60%)
Updated
Jul 3 closing price
Capitalization
1.87B
32 days until earnings call
Interact to see
Advertisement

AMPH vs AMRX

Header iconAMPH vs AMRX Comparison
Open Charts AMPH vs AMRXBanner chart's image
Amphastar Pharmaceuticals
Price$23.20
Change-$0.38 (-1.61%)
Volume$221.78K
Capitalization2.11B
Amneal Pharmaceuticals
Price$8.42
Change+$0.05 (+0.60%)
Volume$898.79K
Capitalization1.87B
AMPH vs AMRX Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. AMRX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and AMRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AMPH: $23.20 vs. AMRX: $8.42)
Brand notoriety: AMPH and AMRX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 42% vs. AMRX: 47%
Market capitalization -- AMPH: $2.11B vs. AMRX: $1.87B
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. AMRX’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileAMRX’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • AMRX’s FA Score: 1 green, 4 red.
According to our system of comparison, AMRX is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while AMRX’s TA Score has 6 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 5 bearish.
  • AMRX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than AMPH.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а +0.09% price change this week, while AMRX (@Pharmaceuticals: Other) price change was +3.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

AMPH is expected to report earnings on Aug 11, 2025.

AMRX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than AMPH: AMRX (90.00) vs AMPH (16.69). AMRX YTD gains are higher at: 6.313 vs. AMPH (-37.517). AMRX has higher annual earnings (EBITDA): 400M vs. AMPH (240M). AMPH has more cash in the bank: 257M vs. AMRX (91.5M). AMPH has less debt than AMRX: AMPH (624M) vs AMRX (2.75B). AMRX has higher revenues than AMPH: AMRX (2.39B) vs AMPH (644M).
AMPHAMRXAMPH / AMRX
Capitalization2.11B1.87B113%
EBITDA240M400M60%
Gain YTD-37.5176.313-594%
P/E Ratio16.6990.0019%
Revenue644M2.39B27%
Total Cash257M91.5M281%
Total Debt624M2.75B23%
FUNDAMENTALS RATINGS
AMPH vs AMRX: Fundamental Ratings
AMPH
AMRX
OUTLOOK RATING
1..100
5924
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
8958
SMR RATING
1..100
4599
PRICE GROWTH RATING
1..100
8746
P/E GROWTH RATING
1..100
9128
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (64) in the Pharmaceuticals Other industry is in the same range as AMRX (90) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (58) in the Pharmaceuticals Major industry is in the same range as AMPH (89) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's SMR Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (99) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Price Growth Rating (46) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMPH (87) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMRX's P/E Growth Rating (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMPH (91) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHAMRX
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
70%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMACX13.950.06
+0.43%
Gabelli Entpr Mergers & Acquisitions C
NAWGX50.690.19
+0.38%
Voya Global High Dividend Low Vol A
WFMDX48.820.11
+0.23%
Allspring Special Mid Cap Value Admin
FBOGX9.820.02
+0.20%
Templeton Global Smaller Comp R6
MGLLX16.690.02
+0.12%
MFS Global Real Estate R3

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-1.61%
AMRX - AMPH
40%
Loosely correlated
+0.60%
ALKS - AMPH
33%
Poorly correlated
-0.52%
PAHC - AMPH
32%
Poorly correlated
+0.21%
HROW - AMPH
32%
Poorly correlated
+3.86%
VTRS - AMPH
30%
Poorly correlated
-0.21%
More

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.60%
PAHC - AMRX
47%
Loosely correlated
+0.21%
VTRS - AMRX
42%
Loosely correlated
-0.21%
EBS - AMRX
40%
Loosely correlated
-1.69%
AMPH - AMRX
40%
Loosely correlated
-1.61%
ZTS - AMRX
39%
Loosely correlated
+0.06%
More